Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Safety and Pharmacokinetics of HTL0018318, a Novel M(1) Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects - Bakker_2021_Drugs.R.D__ |
| Author(s) : Bakker C , van der Aart J , Labots G , Liptrot J , Cross DM , Klaassen ES , Dickinson S , Tasker T , Groeneveld GJ |
| Ref : Drugs R D , : , 2021 |
| Abstract : Bakker_2021_Drugs.R.D__ |
| ESTHER : Bakker_2021_Drugs.R.D__ |
| PubMedSearch : Bakker_2021_Drugs.R.D__ |
| PubMedID: 34164794 |
| Title : Safety, pharmacokinetics, and pharmacodynamics of Gln-1062, a prodrug of galantamine - Bakker_2020_Alzheimers.Dement.(N.Y)_6_e12093 |
| Author(s) : Bakker C , van der Aart J , Hart EP , Klaassen ES , Bergmann KR , van Esdonk MJ , Kay DG , Groeneveld GJ |
| Ref : Alzheimers Dement (N Y) , 6 :e12093 , 2020 |
| Abstract : Bakker_2020_Alzheimers.Dement.(N.Y)_6_e12093 |
| ESTHER : Bakker_2020_Alzheimers.Dement.(N.Y)_6_e12093 |
| PubMedSearch : Bakker_2020_Alzheimers.Dement.(N.Y)_6_e12093 |
| PubMedID: 33083515 |
| Title : Cholinergic and serotonergic modulation of resting state functional brain connectivity in Alzheimer's disease - Klaassens_2019_Neuroimage_199_143 |
| Author(s) : Klaassens BL , van Gerven JMA , Klaassen ES , van der Grond J , Rombouts S |
| Ref : Neuroimage , 199 :143 , 2019 |
| Abstract : Klaassens_2019_Neuroimage_199_143 |
| ESTHER : Klaassens_2019_Neuroimage_199_143 |
| PubMedSearch : Klaassens_2019_Neuroimage_199_143 |
| PubMedID: 31112788 |
| Title : Serotonergic and cholinergic modulation of functional brain connectivity: A comparison between young and older adults - Klaassens_2018_Neuroimage_169_312 |
| Author(s) : Klaassens BL , van Gerven JMA , Klaassen ES , van der Grond J , Rombouts S |
| Ref : Neuroimage , 169 :312 , 2018 |
| Abstract : Klaassens_2018_Neuroimage_169_312 |
| ESTHER : Klaassens_2018_Neuroimage_169_312 |
| PubMedSearch : Klaassens_2018_Neuroimage_169_312 |
| PubMedID: 29258890 |
| Title : First in human study with a prodrug of galantamine: Improved benefit-risk ratio? - Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| Author(s) : Baakman AC , t Hart E , Kay DG , Stevens J , Klaassen ES , Maelicke A , Groeneveld GJ |
| Ref : Alzheimers Dement (N Y) , 2 :13 , 2016 |
| Abstract : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| ESTHER : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| PubMedSearch : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| PubMedID: 29067291 |